LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

LLY

914.82

+1.5%↑

JNJ

239.95

+2.09%↑

ABBV

206.56

+0.92%↑

NVS

150.73

+1.58%↑

MRK

119.31

+2.59%↑

Начало・Списък с акции・Microbot Medical Inc

Microbot Medical Inc

Затворен

2.52 1.2

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.5

Максимум

2.6

Ключови измерители
By Trading Economics
Приходи	-77K -3.6M
Служители	20
EBITDA	-79K -3.6M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+200% upside

Дивиденти
By Dow Jones
Следващи печалби	30.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	29M 169M
Предишно отваряне	1.32
Предишно затваряне	2.52

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

2.52 / 2.57 Подкрепа & съпротива

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

25.03.2026 г., 20:20 ч. UTC

Придобивния, сливания и поглъщания

Infosys Agrees to Acquire Stratus

25.03.2026 г., 23:58 ч. UTC

Печалби

Guming Proposes 2025 Final Dividend of HK$0.50 >1364.HK

25.03.2026 г., 23:58 ч. UTC

Печалби

Guming: Seek to Further Expand Coffee Product Line, Explore New Food Categories >1364.HK

25.03.2026 г., 23:57 ч. UTC

Печалби

Guming: Aim to Expand Store Network in China, Evaluate Overseas Opportunities >1364.HK

25.03.2026 г., 23:57 ч. UTC

Печалби

Guming Store Network Rose 37% on Year to 13,554 Stores as of Dec. 31, 2025 >1364.HK

25.03.2026 г., 23:56 ч. UTC

Печалби

Guming 2025 Rev CNY12.91B Vs. CNY8.79B >1364.HK

25.03.2026 г., 23:56 ч. UTC

Печалби

Guming 2025 Net CNY3.11B Vs. Net CNY1.48B >1364.HK

25.03.2026 г., 23:41 ч. UTC

Пазарно говорене

Nikkei May Trade Rangebound Amid Uncertainty Over U.S.-Iran Talks -- Market Talk

25.03.2026 г., 23:41 ч. UTC

Печалби

These Stocks Are Today's Movers: Arm, Intel, AMD, Firefly Aerospace, Robinhood, JD.com, Sarepta, and More -- Barrons.com

25.03.2026 г., 23:34 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Declines on Possible Technical Correction -- Market Talk

25.03.2026 г., 22:08 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

25.03.2026 г., 22:08 ч. UTC

Пазарно говорене

Synlait Milk's Outlook Depends on Dunsandel -- Market Talk

25.03.2026 г., 22:07 ч. UTC

Печалби

China Mengniu Dairy: Weak Consumer Demand Weighed on Rev >2319.HK

25.03.2026 г., 22:07 ч. UTC

Печалби

China Mengniu Dairy Plans Steady Increase in Dividends For Next Three Years >2319.HK

25.03.2026 г., 22:07 ч. UTC

Печалби

China Mengniu Dairy: 2025 Net Supported by Absence of Impairment Provisions Made Last Year >2319.HK

25.03.2026 г., 22:07 ч. UTC

Печалби

China Mengniu Dairy 2025 Rev CNY82.24B Vs. CNY88.67B >2319.HK

25.03.2026 г., 22:07 ч. UTC

Печалби

China Mengniu Dairy 2025 Net CNY1.55B Vs. Net CNY104.51M >2319.HK

25.03.2026 г., 21:58 ч. UTC

Пазарно говорене

Amplitude Energy Oversold on Isabella-1 Well Disappointment -- Market Talk

25.03.2026 г., 21:37 ч. UTC

Пазарно говорене

Miran: AI and Deregulation Are Positive Supply Shocks To Economy -- Market Talk

25.03.2026 г., 21:14 ч. UTC

Придобивния, сливания и поглъщания

St Barbara: Expects to Record Gain on Sale of Roughly A$500 Million Upon Completion

25.03.2026 г., 21:13 ч. UTC

Придобивния, сливания и поглъщания

St Barbara: All Conditions Satisfied, Waived on Lingbao Deal

25.03.2026 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

Closing M&A Deals Bring Opportunity. Janus Henderson and Other Stocks to Buy. -- Barrons.com

25.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

25.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

25.03.2026 г., 20:33 ч. UTC

Придобивния, сливания и поглъщания

KKR & Co.: Entered Agreement to Sell CoolIT Systems to Ecolab in Transaction Valued at $4.75B >KKR >KKR

25.03.2026 г., 20:31 ч. UTC

Печалби

The SpaceX IPO Is Coming. Cathie Wood's Ark Venture and More Funds to Get in on the Action. -- Barrons.com

25.03.2026 г., 20:15 ч. UTC

Придобивния, сливания и поглъщания

KKR Scores One of Its Best Bets With Sale of Data-Center Cooling Business -- WSJ

25.03.2026 г., 20:15 ч. UTC

Придобивния, сливания и поглъщания

CoolIT Employees Set to Receive Average Payouts of $240,000, Executives Say -- WSJ

25.03.2026 г., 20:15 ч. UTC

Придобивния, сливания и поглъщания

CoolIT Deal Ranks Among KKR's Top-4 Highest Earning Investments in Past 20 Years, Executives Say -- WSJ

25.03.2026 г., 20:15 ч. UTC

Придобивния, сливания и поглъщания

KKR Set to Make 15x Investment From $4.75B Sale of CoolIT to Ecolab, Executives Say -- WSJ

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

200% нагоре

12-месечна прогноза

Среден 7.5 USD 200%

Висок 12 USD

Нисък 5 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

Купи

Задържане

Продай

Според 3 анализатори, дали борсови рейтинги на Microbot Medical Inc през последните 3 месеца.

Техническа оценка

By Trading Central

2.52 / 2.57Подкрепа & съпротива

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.